Over the past 3 decades, the endovascular approach to treating diseases of the thoracic aorta has become the treatment of choice. Recent studies have shown better outcomes of thoracic endovascular aortic repair (TEVAR) in terms of early mortality, morbidity, and length of stay compared with open surgery. 1 Stroke remains one of the most serious complications of TEVAR, having an impact on both patient health status and the associated healthcare costs. [2] [3] [4] However, a major issue is the lack of common definitions and evaluation of stroke or cerebrovascular events among recent TEVAR studies. Therefore, valid information about stroke related to TEVAR is sparse. This is in contrast to the advances that were made over the last few years in understanding the pathophysiology of stroke and in developing modern treatment approaches for acute ischemic stroke.
Recently, Allmen et al 3 performed a systematic review and meta-analysis of stroke incidence in 2594 patients after TEVAR. The analysis demonstrated that stroke is an important morbidity after TEVAR, with a pooled prevalence of 4%. However, in their methodology, the authors used only the terms "stroke" and "neurologic deficit," and they observed moderate heterogeneity in their analysis regarding stroke incidence among studies. In another meta-analysis of TEVAR patients combined with left subclavian artery (LSA) coverage with or without revascularization, 5 the incidence of stroke was 5.8% to 7.8%, with moderate heterogeneity among studies, but only 1 study had provided data regarding the distribution and severity of stroke. In an older meta-analysis of neurologic complications after TEVAR with or without LSA revascularization, 6 there was also no specific definition of cerebrovascular events in the methodology section.
Additionally, recent studies have highlighted that cerebral embolization and neurocognitive decline in TEVAR patients is an insidious complication, so brain injury may be more common than previously recognized, with cerebral infarction in >80% of patients [68% on magnetic resonance imaging (MRI); 12% clinical stroke]. 7 In another study, Kahlert et al 8 found a high incidence (63%) of a pattern suggestive of periprocedural embolization on cerebral diffusion weighted-MRI in patients after TEVAR.
The 2013 American Heart Association (AHA) guidelines 9 proposed an update of the stroke definition for the 21st century. The document highlighted that the term "stroke" should be broadly used to include all of the following: central nervous system (CNS) infarction, ischemic stroke, silent CNS infarction, stroke caused by intracerebral hemorrhage or cerebral venous thrombosis, and stroke not otherwise specified. Similar updated AHA guidelines 10 defined transient ischemic attack (TIA) as a transient episode of neurologic dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute infarction. However, even if TIA symptoms last for only a short period of time, for example, minutes, the episode will be redefined as a stroke if there is imaging evidence of infarction.
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Recently, the Neurologic Academic Research Consortium 11 proposed standardized neurologic endpoints for cardio vascular clinical trials, dividing procedural stroke into the following categories: type 1, overt CNS injuryacutely symptomatic brain or spinal cord injury; type 2, covert CNS injury-acutely asymptomatic brain or spinal cord injury detected by neuroimaging; and type 3, neurologic dysfunction (acutely symptomatic) without CNS injury. Each type is subdivided into subtypes describing the various mechanisms of stroke, including ischemic, hemorrhagic, and global hypoxia. Additionally, in their recommendations, the consortium suggested criteria that allow recognition of subclinical events.
In a state-of-art review, Devgun et al 12 highlighted the importance of definition and reporting of cerebrovascular events after cardiovascular procedures, such as coronary artery bypass grafting, isolated valve surgery, and carotid endarterectomy. In the current European Society for Vascular Surgery guidelines, 13 there is no specific definition of stroke or cerebrovascular event after TEVAR or any recommendation on how to document such an event.
In light of recent developments in aortic arch surgery and new techniques in endovascular aortic arch repair, [13] [14] [15] universal and unambiguous definitions of stroke and neurovascular events become of paramount importance to understanding the etiology of stroke in TEVAR procedures and to forming a preventive strategy both during and after the procedure. Categorizing stroke severity as suggested by the Neurologic Academic Research Consortium 11 in all TEVAR reports will provide a transparent tool to make the comparison of techniques plausible and acceptable to multiple specialties. Additional information regarding the distribution of strokes in the cerebrovascular territories (posterior vs anterior) as well as information regarding the discharge functional status of stroke patients should optimally be reported to acquire as much information as possible about the consequences of this major complication. A more interdisciplinary approach for these patients with case discussion in neurovascular boards and advanced perioperative imaging should be encouraged.
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